Skip to main content

Qianben Wang

Banks Anderson, Sr. Distinguished Professor
Pathology
Room 1027A, GSRB1, Box #103864,, Durham, NC 27710

Selected Grants


Elucidating alternative polyadenylation regulation during prostate cancer progression to castration-resistance

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2024 - 2029

Targeting MED31-driven transcription recycling in lethal prostate cancer

ResearchPrincipal Investigator · Awarded by National Cancer Institute · 2023 - 2028

Cell and Molecular Biology Training Program

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2021 - 2026

Targeting oncogenomic function of N-Myc to inhibit neuroendocrine prostate cancer visceral metastasis

ResearchPrincipal Investigator · Awarded by Department of Defense · 2023 - 2026

Computational and Experimental Modeling of Alternative Polyadenylation

ResearchPrincipal Investigator · Awarded by University of California - Irvine · 2022 - 2026

Elucidating alternative polyadenylation regulation during prostate cancer progression to castration-resistance

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2024 - 2029

Targeting MED31-driven transcription recycling in lethal prostate cancer

ResearchPrincipal Investigator · Awarded by National Cancer Institute · 2023 - 2028

Cell and Molecular Biology Training Program

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2021 - 2026

Targeting oncogenomic function of N-Myc to inhibit neuroendocrine prostate cancer visceral metastasis

ResearchPrincipal Investigator · Awarded by Department of Defense · 2023 - 2026

Computational and Experimental Modeling of Alternative Polyadenylation

ResearchPrincipal Investigator · Awarded by University of California - Irvine · 2022 - 2026

Inhalable Cas13d-based nanotherapy for pan-coronavirus infection: Using SARS-CoV-2 Omicron as a model

ResearchPrincipal Investigator · Awarded by North Carolina Biotechnology Center · 2024 - 2026

Systems analysis of the prostate cancer epigenome

ResearchUnit Lead · Awarded by National Institutes of Health · 2020 - 2025

Cas13d-based nanotherapy targeting undruggable transcription factor HoxB13 to inhibit prostate cancer metastasis

ResearchPrincipal Investigator · Awarded by North Carolina Biotechnology Center · 2023 - 2025

Adjuvant Comparison for Peanut Allergy Immunotherapy

ResearchCo Investigator · Awarded by National Institutes of Health · 2022 - 2025

Genetic and Genomics Training Grant

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2020 - 2025

Role of JMJD1A modifications in castration resistance of prostate cancer

ResearchPrincipal Investigator · Awarded by University of Maryland, Baltimore · 2022 - 2025

Exploiting Ferroptosis for the Treatment of RB1-Deficient Lethal Prostate Cancer

ResearchCo-Mentor · Awarded by Department of Defense · 2022 - 2024

Targeting neuroendocrine prostate cancer by engineering 3' untranslated regions

ResearchPrincipal Investigator · Awarded by Department of Defense · 2020 - 2024

Targeting the Oncogenomic Function of the E2F8 Transcription Factor in Lethal Cancer

ResearchMentor · Awarded by Department of Defense · 2022 - 2024

Systems Analysis of Epigenomic Architecture in Cancer Progression (Outreach Core)

ResearchPrincipal Investigator · Awarded by University of Texas Health Science Center at San Antonio · 2019 - 2023

Systems Analysis of Epigenomic Architecture in Cancer Progression (Project 2: Fine-scale nucleosome repositioning of enhancers for hormone-independent genomic function)

ResearchPrincipal Investigator · Awarded by University of Texas Health Science Center at San Antonio · 2017 - 2023

FOXA2-targeted organ-selective nanotherapy for prostate cancer visceral metastasis

ResearchPrincipal Investigator · Awarded by Mike Slive Foundation · 2022 - 2022

Role of oncogenic phosphorylated MED1 in aggressive prostate cancer

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2017 - 2022

Systems Analysis of Epigenomic Architecture in Cancer Progression (Administrative Core)

ResearchPrincipal Investigator · Awarded by University of Texas Health Science Center at San Antonio · 2017 - 2022

Novel genomic mechanism for ligand-dependent transcription by androgen receptor

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2017 - 2022

Targeting castration-resistant prostate cancer by engineering 3'UTR

ResearchMentor · Awarded by Department of Defense · 2020 - 2022

Novel Tumor Suppressive Role of Phosphodiesterases in Prostate Cancer

ResearchPrincipal Investigator · Awarded by Ohio State University · 2017 - 2021

Systems Analysis of Epigenomic Architecture in Cancer Progression (Carryover)

ResearchPrincipal Investigator · Awarded by University of Texas Health Science Center at San Antonio · 2020 - 2021

Organization and Function of Cellular Structure

Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 1975 - 2020

Population/single-cell profiling of chromatin accessibility for hormone-dependent cancers

ResearchPrincipal Investigator · Awarded by University of Texas Health Science Center at San Antonio · 2018 - 2019

External Relationships


  • NIH, Society of Basic Urological Research, Dana-Farber Cancer Institute, Wayne State University , Serican Academy of Urology, Journal editorial board

This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.